It's time to break free of the #EchoChamber and read the #news, the way it should be. We help you develop an informed, balanced perspective by showing the most compelling opinions on ALL sides of a debate.
Stay in the know and subscribe to our newsletter: https://t.co/RVjTzukhRA
@eScarry from @dcexaminer states: "Joe Biden at least sounded sincere when he said on Saturday that 'this is the time to heal in America.' But liberals must have howled in amusement at the idea. They have no interest in unity because they're not nice. They're vindictive."
@davidharsanyi from @DailySignal says: "I’m not at all interested in finding accord with those who want to overturn the Hyde Amendment, thereby making late-term abortion a state-funded practice... Like many others, I find disunity quite therapeutic."
The editorial board from @dcexaminer says: "Trump’s obligation here is clear, even if his frustration is understandable. Fewer than 50,000 votes, shifted in three states, could have flipped the election to him through an Electoral College tie."
The editorial board from @reviewjournal states: "Mr. Trump expected no less from the Obama administration in 2016 even as Hillary’s acolytes floated ways to manipulate the Electoral College vote. Mr. Biden deserves the same consideration today..."
Roger Clegg from @NRO notes: "Well, the aim was always to get this issue back before the Supreme Court, and the sooner the better. It’s also good news that the appellate judges upheld the plaintiffs’ standing here."
The editorial board from @WSJ explains: "The time may also be ripe politically. The U.S. is far more ethnically diverse than it once was, with many more groups qualifying as minorities. In the Harvard case, Asian-Americans are the aggrieved party, not white Americans.
@DrMarcSiegel from @FoxNews states: "Instead of celebrating a great moment for vaccine science, several key opponents of the current administration have actually come out and undermined the new vaccine, at the worst possible time because public compliance is by no means assured."
The editorial board from @WSJ notes: "Pfizer’s announcement Monday that its vaccine for Covid-19 was 90% effective in late-stage trials is the best news of a dismal 2020. The apparent breakthrough is a credit to the innovative capacity of the private pharmaceutical industry."